Dr Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Friday, July 30, 2021, to consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2021 and to consider the proposal of declaration of interim dividend, if any, for the Financial Year 2021-22.
The above information is a part of company’s filings submitted to BSE.